Product Code: CHBE
TABLE OF CONTENTS
List Of Contents And Tables
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 2 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2016-2021
Table 4 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 5 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 6 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021
Table 8 Distribution of Consumer Health by Format: % Value 2016-2021
Table 9 Distribution of Consumer Health by Format and Category: % Value 2021
Table 10 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN BELGIUM
KEY DATA FINDINGS
2021 DEVELOPMENTS
Analgesics return to almost-normal sales in 2021, following both stockpiling and disruptions seen in 2020
Limited incidences of cold and influenza seen, due to COVID-19 health precautions
Dafalgan is the big winner of 2020-2021, keeping UPSA Medica in its leading place
PROSPECTS AND OPPORTUNITIES
Acetaminophen set to benefit from the return of colds and flu as restrictions ease, alongside being used to treat vaccination side effects
Analgesics continue to face challenges, including the weight of maturity, low innovation, competition from other products, and seasonal factors
Switch towards generic products over more expensive brands has been accelerated by the event of the pandemic
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2016-2021
Table 13 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 14 NBO Company Shares of Analgesics: % Value 2017-2021
Table 15 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 16 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN BELGIUM
KEY DATA FINDINGS
2021 DEVELOPMENTS
Cough, cold and allergy (hay fever) remedies see a natural recovery due to a high-pollen spring and consumers' concerns about respiratory ailments
Fewer doctors' consultations for coughs, cold and influenza in 2020 badly impacted cough remedies, decongestants and pharyngeal preparations
Top brands survive the storm, whilst many others are forced to take a back seat
PROSPECTS AND OPPORTUNITIES
2022 bounce-back followed by declining sales, as cough and cold remedies continue to face challenges
Innovation and advertising plans dampened by the increasingly mild winters
Rising competition from natural remedies in a health-aware population
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2021
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2021
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2021-2026
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2021-2026
DIGESTIVE REMEDIES IN BELGIUM
KEY DATA FINDINGS
2021 DEVELOPMENTS
Pandemic precautionary measures also negate gastroenteritis, thus lowering the need for a number of digestive remedies
Boom in domestic tourism and associated car travel supports sales of motion sickness remedies
Norgine maintains and strengthens lead achieved over Janssen-Cilag
PROSPECTS AND OPPORTUNITIES
Strong bounce backs expected in 2022, with slower sales over the forecast period due to disparate performances
Cannibalisation expected, due to low product recognition in a number of categories
Growing trend towards more natural digestive remedies, following domperidone and ranitidine scandals
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2016-2021
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2016-2021
Table 26 NBO Company Shares of Digestive Remedies: % Value 2017-2021
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2018-2021
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2021-2026
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2021-2026
DERMATOLOGICALS IN BELGIUM
KEY DATA FINDINGS
2021 DEVELOPMENTS
Dermatologicals affected by lower incidences of seasonal ailments, due to supportive nature of such products
Specific sub-category impacts all contribute to a slower recovery
Janssen-Cilag maintains its lead, despite losing shares to competitors
PROSPECTS AND OPPORTUNITIES
A stronger foothold in pharmacies will benefit dermatologicals, however strong competition is expected from added value Rx products
The event of the pandemic accelerates the already-high demand for natural products and paves the way for innovation
Recovery will be boosted by a return to social lifestyle activities
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2016-2021
Table 31 Sales of Dermatologicals by Category: % Value Growth 2016-2021
Table 32 NBO Company Shares of Dermatologicals: % Value 2017-2021
Table 33 LBN Brand Shares of Dermatologicals: % Value 2018-2021
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2018-2021
Table 35 Forecast Sales of Dermatologicals by Category: Value 2021-2026
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026
NRT SMOKING CESSATION AIDS IN BELGIUM
KEY DATA FINDINGS
2021 DEVELOPMENTS
Pandemic has mixed impact on NRT smoking cessation aids, from cessation for health reasons to smoking due to stress
NRT sees weakened competition from e-vapour products, due to tough restrictions on tobacco
Nicorette maintains its top place, giving Janssen-Cilag a strong lead in a limited category
PROSPECTS AND OPPORTUNITIES
Potential deregulation and faster-acting products set to bolster sales over the forecast period
E-vape products continue to pose a threat, as new surveys indicate they are more effective to assist smoking cessation than NRT products
Limited price hikes on legal tobacco and illicit tobacco trade make smoking more affordable, in another potential obstacle for NRT
CATEGORY DATA
Table 37 Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021
Table 38 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021
Table 39 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2017-2021
Table 40 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2018-2021
Table 41 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2021-2026
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2021-2026
SLEEP AIDS IN BELGIUM
KEY DATA FINDINGS
2021 DEVELOPMENTS
Sleep aids maintain healthy sales due to highly stressed consumers seeking restful sleep during the pandemic
Melatonin and magnesium remain key as popular ingredients, whilst herbal remedies enjoy a resurgence in line with natural trends
Metagenics Belgium maintains its lead, despite losing shares to its competitors
PROSPECTS AND OPPORTUNITIES
Sales to remain positive, with a growing preference for online sales and OTC sleep aids, over traditional Rx variants
Challenges ahead in an increasingly competitive landscape, with unique selling points and significant advertising key to sales
Growingly blur distinction with dietary supplements but maybe a little help from CBD
CATEGORY INDICATORS
Table 43 Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021
Table 44 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021
Table 45 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2017-2021
Table 46 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2018-2021
Table 47 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2021-2026
Table 48 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2021-2026
CATEGORY DATA
Table 49 Sales of Sleep Aids: Value 2016-2021
Table 50 Sales of Sleep Aids: % Value Growth 2016-2021
Table 51 NBO Company Shares of Sleep Aids: % Value 2017-2021
Table 52 LBN Brand Shares of Sleep Aids: % Value 2018-2021
Table 53 Forecast Sales of Sleep Aids: Value 2021-2026
Table 54 Forecast Sales of Sleep Aids: % Value Growth 2021-2026
EYE CARE IN BELGIUM
KEY DATA FINDINGS
2021 DEVELOPMENTS
Significant delays for ophthalmologists' appointments continue to place downward pressure on eye care sales
Pre-pandemic challenges of high turnovers creating cannibalisation continue to deter new investments
Thea Pharma maintains its company lead, despite GSK's Terramycin taking top brand place in a fiercely competitive landscape
PROSPECTS AND OPPORTUNITIES
Will longer waiting times for consultations in the wake of COVID-19 further boost self-medication?
Ongoing home-working trends and an ageing population support ongoing sales in eye care
Ophthalmologists remain key to promote products and provide free samples, thus long appointment waiting time will dampen growth
CATEGORY DATA
Table 55 Sales of Eye Care by Category: Value 2016-2021
Table 56 Sales of Eye Care by Category: % Value Growth 2016-2021
Table 57 NBO Company Shares of Eye Care: % Value 2017-2021
Table 58 LBN Brand Shares of Eye Care: % Value 2018-2021
Table 59 Forecast Sales of Eye Care by Category: Value 2021-2026
Table 60 Forecast Sales of Eye Care by Category: % Value Growth 2021-2026
WOUND CARE IN BELGIUM
KEY DATA FINDINGS
2021 DEVELOPMENTS
Slow recovery in wound care is dependent on a return to pre-pandemic lifestyles, with schools open and sporting activities resumed
Unfavourable conditions remain for innovations in niche and added-value propositions
Beiersdorf's Hansaplast brand remains the clear winner, but competition is rising from cheaper private label brands and economy options
PROSPECTS AND OPPORTUNITIES
Residual effects of COVID-19 on consumer behaviours will herald a slow recovery
Price-sensitive consumers seek economical products, thus negating the need for innovation in niche and added-value propositions
First aid kits set to struggle, whilst private labels and online players see opportunities ahead
CATEGORY DATA
Table 61 Sales of Wound Care by Category: Value 2016-2021
Table 62 Sales of Wound Care by Category: % Value Growth 2016-2021
Table 63 NBO Company Shares of Wound Care: % Value 2017-2021
Table 64 LBN Brand Shares of Wound Care: % Value 2018-2021
Table 65 Forecast Sales of Wound Care by Category: Value 2021-2026
Table 66 Forecast Sales of Wound Care by Category: % Value Growth 2021-2026
VITAMINS IN BELGIUM
KEY DATA FINDINGS
2021 DEVELOPMENTS
Vitamins continue to benefit from enhanced health trend due to COVID-19, albeit sales have normalised following the boom in 2020
Multivitamins receive a boost in popularity due to immunity claims, in contrast to trends seen pre-pandemic
Galephar maintains its lead, thanks to its strength in single vitamins; although multivitamin players are tipped as ones to watch
PROSPECTS AND OPPORTUNITIES
Robust growth to continue thanks to enhanced health and wellness trends, although the pandemic-related boom is over
Multiple reasons why multivitamins will not enjoy their new popularity long-term
Targeted alternatives set to cannibalise generic options
CATEGORY DATA
Table 67 Sales of Vitamins by Category: Value 2016-2021
Table 68 Sales of Vitamins by Category: % Value Growth 2016-2021
Table 69 Sales of Multivitamins by Positioning: % Value 2016-2021
Table 70 NBO Company Shares of Vitamins: % Value 2017-2021
Table 71 LBN Brand Shares of Vitamins: % Value 2018-2021
Table 72 Forecast Sales of Vitamins by Category: Value 2021-2026
Table 73 Forecast Sales of Vitamins by Category: % Value Growth 2021-2026
DIETARY SUPPLEMENTS IN BELGIUM
KEY DATA FINDINGS
2021 DEVELOPMENTS
A return to more typical sales figures for non-essential healthcare products, including dietary supplements
Immunity-support and mood enhancement/relaxation claims remain relevant
Merck Consumer Healthcare maintains its company lead, thanks to targeting its products to meet consumer trends
PROSPECTS AND OPPORTUNITIES
Ongoing focus on immunity boosting and mood enhancing/relaxing supplements
Ongoing economic recession will speed up internal cannibalisation in a category well known for its short lifecycles
Pandemic gives respite for semi ethical players, as unscrupulous offerings fall by the wayside
CATEGORY DATA
Table 74 Sales of Dietary Supplements by Category: Value 2016-2021
Table 75 Sales of Dietary Supplements by Category: % Value Growth 2016-2021
Table 76 Sales of Dietary Supplements by Positioning: % Value 2016-2021
Table 77 NBO Company Shares of Dietary Supplements: % Value 2017-2021
Table 78 LBN Brand Shares of Dietary Supplements: % Value 2018-2021
Table 79 Forecast Sales of Dietary Supplements by Category: Value 2021-2026
Table 80 Forecast Sales of Dietary Supplements by Category: % Value Growth 2021-2026
WEIGHT MANAGEMENT AND WELLBEING IN BELGIUM
KEY DATA FINDINGS
2021 DEVELOPMENTS
Weight management and wellbeing return to positive growth figures as consumers prepare for their beach holidays
Ongoing challenges indicate a sluggish full recovery, with peaks, troughs, and high-priced products losing consumer confidence
Herbalife maintains overall lead, whilst Forte Pharma's Slimboost 24 is tipped as a product to watch
PROSPECTS AND OPPORTUNITIES
Stronger recovery linked to a rebound in travel and tourism, although challenges remain for non-essential products
Supplement nutrition drinks and slimming teas expected to see the best results over the forecast period
Dynamic small-and-medium-sized players who offer natural solutions are expected to fare well
CATEGORY DATA
Table 81 Sales of Weight Management and Wellbeing by Category: Value 2016-2021
Table 82 Sales of Weight Management and Wellbeing by Category: % Value Growth 2016-2021
Table 83 NBO Company Shares of Weight Management and Wellbeing: % Value 2017-2021
Table 84 LBN Brand Shares of Weight Management and Wellbeing: % Value 2018-2021
Table 85 Forecast Sales of Weight Management and Wellbeing by Category: Value 2021-2026
Table 86 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2021-2026
SPORTS NUTRITION IN BELGIUM
KEY DATA FINDINGS
2021 DEVELOPMENTS
Sports nutrition sees a degree of recovery in 2021, following the significant declines seen in 2020 due to the closure of gymnasiums
The impact of gymnasium closures is greater than just seen on the surface, with dozens of thousands of members lost
Variable performances for different players, with QNT maintaining its company lead whilst competing brand Isostar tops multiple sub-categories
PROSPECTS AND OPPORTUNITIES
Positive outlook for sports nutrition as consumers return to gymnasiums after months of inactivity and sporting events resume
Crucial for struggling gymnasiums to recover to aid the recovery of sports nutrition
Many new product developments and novelties in the pipeline, with players focusing on omnichannel strategies
CATEGORY DATA
Table 87 Sales of Sports Nutrition by Category: Value 2016-2021
Table 88 Sales of Sports Nutrition by Category: % Value Growth 2016-2021
Table 89 NBO Company Shares of Sports Nutrition: % Value 2017-2021
Table 90 LBN Brand Shares of Sports Nutrition: % Value 2018-2021
Table 91 Forecast Sales of Sports Nutrition by Category: Value 2021-2026
Table 92 Forecast Sales of Sports Nutrition by Category: % Value Growth 2021-2026
HERBAL/TRADITIONAL PRODUCTS IN BELGIUM
KEY DATA FINDINGS
2021 DEVELOPMENTS
COVID-19 health concerns and associated stress boost interest in herbal/tradition (natural) products
Decline in common seasonal ailments places downwards pressure on equivalent herbal/traditional remedies as well as standard variants
Tilman maintains its top lead place, as domestic players benefit from their agility and consumer trust during uncertain times
PROSPECTS AND OPPORTUNITIES
Medicinal scandals boost popularity of herbal/traditional products, with particular scope for growth in natural blood pressure remedies
Strong potential in dietary supplements, sleep aids, dermatologicals, digestive remedies and topical analgesics
Players need to avoid repeating past mistakes: profit-killing price wars, short lifecycle products, and making unaccountable claims
CATEGORY DATA
Table 93 Sales of Herbal/Traditional Products by Category: Value 2016-2021
Table 94 Sales of Herbal/Traditional Products by Category: % Value Growth 2016-2021
Table 95 NBO Company Shares of Herbal/Traditional Products: % Value 2017-2021
Table 96 LBN Brand Shares of Herbal/Traditional Products: % Value 2018-2021
Table 97 Forecast Sales of Herbal/Traditional Products by Category: Value 2021-2026
Table 98 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2021-2026
PAEDIATRIC CONSUMER HEALTH IN BELGIUM
KEY DATA FINDINGS
2021 DEVELOPMENTS
Lower rates of seasonal ailments and parents' reluctance to self-medicate children lead to depressed sales
Differing performances for different products, depending on consumer trends
Janssen-Cilag strengthens the leadership it captured from Boots Healthcare, thanks to the preference for acetaminophen over ibuprofen
PROSPECTS AND OPPORTUNITIES
Depressed growth set to continue, due to myriad factors already placing pressure on paediatric consumer health pre-pandemic
Competition from medical devices, high risk investments and ethical issues lead players to focus on products with a natural positioning
Disaffection for paediatric ibuprofen and aspirin expected to persist, with higher levels of scrutiny expected over the forecast period
CATEGORY DATA
Table 99 Sales of Paediatric Consumer Health by Category: Value 2016-2021
Table 100 Sales of Paediatric Consumer Health by Category: % Value Growth 2016-2021
Table 101 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2016-2021
Table 102 NBO Company Shares of Paediatric Consumer Health: % Value 2017-2021
Table 103 LBN Brand Shares of Paediatric Consumer Health: % Value 2018-2021
Table 104 Forecast Sales of Paediatric Consumer Health by Category: Value 2021-2026
Table 105 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2021-2026
